The currently accepted definition of osteoporosis is “systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture risk”.
Bone mineral density can be measured with reasonable accuracy. These tests form the basis for diagnosis of osteoporosis and the prediction of fracture risk. Bone mass refers to the amount of bone tissue contained in the skeleton. Bone mass can be expressed in terms of bone mineral content (the totalgrams of bone mineral within a given area of bone) or in terms of bone mineral density (the bone mineral content normalized for the projected
Normally bone density peaks between the ages of 30 to 40 and in subsequent years the bone density decreases.
If the decrease is significant enough, the so called “fracture threshold” is reached. At this level of bone density the patient is at significant risk of fracture. These thresholds are reached at different ages and the extend of bone loss
varies depending on the peak bone mass and generic and environmental factors, including activity level and diet.
The decrease of bone density in post-menopausal women is significantly greater than in pre-menopausal women or men. The average annual bone loss in post-menopausal women is 1% – 2% and in men 0.2% – 0.5%. Although the rate of bone loss in women is the highest in the years after the menopause, it continues in many patients for many years and
increases again after the age of 70. Annual losses can even reach 3% -5% during the first years following the menopause. In women the major cause of bone loss and osteoporosis is estrogen withdrawal, most commonly associated with the menopause and declining ovarian function, but any cause of estrogen deficiency can cause bone loss.
“Electromagnetic field treatment for Osteoporosis”. © Ben Philipson Curatronic Ltd.